The Department of Gastroenterology at Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China.
The Department of Urology at Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China.
Adv Nutr. 2024 Mar;15(3):100166. doi: 10.1016/j.advnut.2023.100166. Epub 2024 Feb 23.
This meta-analysis was undertaken to determine the predictive value of Healthy Eating Index (HEI)-2015 in all-cause, cancer-cause, and cardiovascular disease (CVD)-cause mortality. This review was registered with PROSPERO as CRD42023421585. PubMed and Web of Science were searched for articles published by September 15, 2023. The hazard ratio (HR) was calculated with exact confidence intervals (CIs) of 95%. Statistical heterogeneity among studies was measured by Cochran's Q test (χ) and the I statistic. Eighteen published studies were finally identified in this meta-analysis. The results showed that the HEI-2015 was associated with all-cause mortality either as a categorical variable (HR: 0.80; 95% CI: 0.79, 0.82) or continuous variable (HR: 0.90; 95% CI: 0.88, 0.92). The HEI-2015 was also associated with cancer-cause mortality as categorical variable (HR: 0.81; 95% CI: 0.78, 0.83) or continuous variable (HR: 0.90; 95% CI: 0.81, 0.99). The categorical HEI-2015 was also independently correlated with decreasing CVD-cause mortality (HR: 0.81; 95% CI: 0.75, 0.87). A nonlinear dose-response relation between the HEI-2015 and all-cause mortality was found. In the linear dose-response analysis, the risk of mortality from cancer decreased by 0.42% per 1 score increment of the HEI-2015 and the risk of CVD-cause mortality decreased by 0.51% with the increment of the HEI-2015 per 1 score. Our analysis indicated a significant relationship between the HEI-2015 and all-cause, cancer-cause, and CVD-cause mortality.
这项荟萃分析旨在确定健康饮食指数(HEI-2015)在全因、癌症和心血管疾病(CVD)死亡率方面的预测价值。本综述已在 PROSPERO 注册,注册号为 CRD42023421585。检索了截至 2023 年 9 月 15 日发表在 PubMed 和 Web of Science 上的文章。使用精确置信区间(95%CI)计算风险比(HR)。通过 Cochran's Q 检验(χ)和 I 统计量测量研究之间的统计学异质性。这项荟萃分析最终确定了 18 项已发表的研究。结果表明,HEI-2015 与全因死亡率相关,无论是作为分类变量(HR:0.80;95%CI:0.79,0.82)还是连续变量(HR:0.90;95%CI:0.88,0.92)。HEI-2015 也与癌症死亡率相关,无论是作为分类变量(HR:0.81;95%CI:0.78,0.83)还是连续变量(HR:0.90;95%CI:0.81,0.99)。分类的 HEI-2015 也与降低 CVD 死亡率独立相关(HR:0.81;95%CI:0.75,0.87)。发现 HEI-2015 与全因死亡率之间存在非线性剂量-反应关系。在线性剂量-反应分析中,HEI-2015 每增加 1 分,癌症死亡率的风险降低 0.42%,HEI-2015 每增加 1 分,CVD 死亡率的风险降低 0.51%。我们的分析表明,HEI-2015 与全因、癌症和 CVD 死亡率之间存在显著关系。